[go: up one dir, main page]

FR2337134A2 - NEW DERIVATIVES OF LYSERGIC ACID, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS - Google Patents

NEW DERIVATIVES OF LYSERGIC ACID, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS

Info

Publication number
FR2337134A2
FR2337134A2 FR7700021A FR7700021A FR2337134A2 FR 2337134 A2 FR2337134 A2 FR 2337134A2 FR 7700021 A FR7700021 A FR 7700021A FR 7700021 A FR7700021 A FR 7700021A FR 2337134 A2 FR2337134 A2 FR 2337134A2
Authority
FR
France
Prior art keywords
alpha
methyl
derivs
cpds
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR7700021A
Other languages
French (fr)
Inventor
Paul Stadler
Peter Stutz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2337134A2 publication Critical patent/FR2337134A2/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Lysergic acids derivs. of formula (I) and their acid addn. salts are novel cpds. (where R is 3-pyridyl, x y is -CH=C and the -CH2SR gp. has beta configuration or R is 2-pyridyl, x y is -CH=C or -CH2-CH and the -CH2SR gp. has alpha-configuration). Cpds. (I) are administered orally rectally or parenterally in daily doses of 1-100mg taken as one or several unit doses. The central dopaminergis stimulatory activity is potentialised by phosphodiesterase inhibitors such as theophylline, caffeine, 4-amino-1H-pyrazolo(3,4-b)pyridine-5-carboxylic acid derivs, 4-(3,4-dimethoxybenzyl)-2-imidazolidinone and analogous derivs and minor tranquillisers such as benzodiazepines and dibenzazepines (I) may be administered, with the phosphodiesterase inhibitor, in daily doses of 0.5-50mg; the ratio (I):phosphodiesterase inhibitor being 1:10 to 1:50. The three cpds. which may be prepd. by the methods of the parent patent comprise 6-methyl-8 beta-(3-pyridylthiometyl)DELTA 9-ergolene, 6-methyl-5 alpha-(2-pyridylthiomethyl)-ergoline and 6-methyl-8 alpha-(2-pyridylthiomethyl)-DELTA 9-ergolene.
FR7700021A 1976-01-02 1977-01-03 NEW DERIVATIVES OF LYSERGIC ACID, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS Pending FR2337134A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4976 1976-01-02

Publications (1)

Publication Number Publication Date
FR2337134A2 true FR2337134A2 (en) 1977-07-29

Family

ID=9697490

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7700021A Pending FR2337134A2 (en) 1976-01-02 1977-01-03 NEW DERIVATIVES OF LYSERGIC ACID, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS

Country Status (8)

Country Link
JP (1) JPS5285197A (en)
AU (1) AU2103877A (en)
BE (1) BE850051R (en)
DE (1) DE2657771A1 (en)
FR (1) FR2337134A2 (en)
IL (1) IL51195A0 (en)
NL (1) NL7614523A (en)
ZA (1) ZA767716B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2466465A1 (en) * 1979-10-01 1981-04-10 Lilly Co Eli DERIVATIVES OF D-6-N-PROPYLERGOLINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2466465A1 (en) * 1979-10-01 1981-04-10 Lilly Co Eli DERIVATIVES OF D-6-N-PROPYLERGOLINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

Also Published As

Publication number Publication date
AU2103877A (en) 1978-07-13
BE850051R (en) 1977-06-30
DE2657771A1 (en) 1977-07-14
JPS5285197A (en) 1977-07-15
ZA767716B (en) 1978-08-30
NL7614523A (en) 1977-07-05
IL51195A0 (en) 1977-02-28

Similar Documents

Publication Publication Date Title
HUP9702219A2 (en) 6-[4-(acylamino)benzoyl]-pyrazolo[3,4-d]thieno[3,2-b]azepine derivatives, process for their preparation and pharmaceutical compositions containing them
EA199800907A1 (en) DERIVATIVES OF CARBOLINE
FI900307A0 (en) Process for the preparation of therapeutically active 3- [3-oxo- (2,3) -dihydropyridazin-6-yl] -2-phenylpyrazolo [1,5-a] pyridine derivatives
SE9402558D0 (en) New use of azatricyclo derivatives and pharmaceutical compositions containing the same
US3954734A (en) Novel antibacterial amide compounds and process means for producing the same
NL300084I1 (en) Novel thiophenecarboxylic acid esters of amino alcohols, their quaternization products, and the preparation and use of these compounds.
FI906438A0 (en) Process for the preparation of novel therapeutically useful A-nor-steroid-3-carboxylic acid derivatives
FR2523582B1 (en) NOVEL 1H-PYRAZOLO (1,5-A) SUBSTITUTED PYRIMIDINES, USEFUL IN PARTICULAR AS ANTI-INFLAMMATORY AND ANALGESIC DRUGS, AND PROCESS FOR THEIR PREPARATION
Baldwin et al. 2-Pyridylimidazoles as inhibitors of xanthine oxidase
IE811513L (en) Benzisoselenazolones
ZA885684B (en) 1,4-dihydropyridines,process for preparation thereof and their application as medicinal products
IE45439L (en) Penicillanic acid derivatives
FR2337134A2 (en) NEW DERIVATIVES OF LYSERGIC ACID, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
IE39102L (en) Piperazine derivatives
GB1530413A (en) 5,8-dihydro-5-oxopyrido(2,3-d)pyrimidines
ES2013379A6 (en) Antitumor 6-sulfenamide, 6-sulfinamide and 6-sulfonamide purines, purine nucleosides, purine nucleotides and related compounds
ES8304937A1 (en) Derivatives of substituted 2-amino-pyridine, process for their preparation, their use in medicaments and preparation thereof.
IE36441B1 (en) New pyridylpiperazines and process for their preparation
ES2046528T3 (en) HETEROTETRACICLIC DERIVATIVES OF LACTAMS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS BASED ON THE SAME.
FR2703048B1 (en) NOVEL N-BENZYLPIPERAZINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2373541A1 (en) NEW SULFAMOYL DERIVATIVES OF 8B-AMINOMETHYLERGOLINE USEFUL IN PARTICULAR AS SEROTONIN ANTAGONISTS AND THEIR PROCESS FOR PREPARATION
GB1526126A (en) Pyrazolopyridine ketones
IE38141B1 (en) New 3,4-dihydropyridones their production and their medicinal use
BE844402A (en) NEW ACID DERIVATIVES (& -AMINOW- (METHYLENEDIOXY-3,4 PHENYL) ACYLAMIDO) -7 CEPHALOSPORANIC, USEFUL IN PARTICULAR AS ANTIBACTERIALS, AND THEIR PROCESS FOR PREPARATION
AU586707B2 (en) New 2-(2-thienyl)-imidazo(4,5-c)pyridine derivatives and salts thereof, processes for their preparation and pharmaceutical products containing these